bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: N O S A J J M A M F J
2016: D N

 
  Other news for:
Lymphoma
 Resources from HONselect
Calquence Approved for Mantle Cell Lymphoma

By Scott Roberts

TUESDAY, Oct. 31, 2017 (HealthDay News) -- Calquence (acalabrutinib) has been approved by the U.S. Food and Drug Administration to treat adults with mantle cell lymphoma.

Mantle cell is an aggressive, fast-growing non-Hodgkin lymphoma, a cancer of the lymph system. Though it represents only 3 percent to 10 percent of non-Hodgkin cases in the United States, the cancer usually has spread by the time it's detected, the FDA said in a news release on Tuesday.

"For patients who have not responded to treatment or who have relapsed, Calquence provides a new treatment option that has shown high rates or response for some patients in initial studies," said Dr. Richard Pazdur, director of the agency's Oncology Center of Excellence.

Calquence is a kinase inhibitor that's designed to block an enzyme that cancer cells use to multiply, the FDA said.

The drug was evaluated in a clinical study of 124 people with mantle cell lymphoma who had received at least one prior treatment. Some 81 percent of trial participants given the drug had a complete or partial response.

The most common side effects included headache, diarrhea, bruising, muscle pain and low red blood cell count (anemia). More serious adverse reactions included bleeding, infections, irregular heartbeat and other cancers, the FDA said.

Calquence is produced by AstraZeneca, based in the United Kingdom.

More information

The FDA has more about this approval.

SOURCE: Oct. 31, 2017 press release, U.S. Food and Drug Administration

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=728055

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Cells
Lymphoma
Neoplasms
Therapeutics
Infection
Adult
Erythrocyte Count
Blood Cell Count
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact